Hematologic Considerations in Cerebrovascular Surgery

  • Charles A. OwenJr.
  • E. J. Walter Bowie


Surgical management of patients with cerebrovascular disease requires an appreciation of the normal mechanism of coagulation and clot lysis. This chapter provides the basis for understanding the pathologic processes involved in cerebral thromboembolism and its treatment with antiplatelet aggregating agents and anticoagulants. It establishes the rationale for antifibrinolytic treatment of aneurysms and provides an insight into the assessment of the coagulopathies encountered in some patients with intracranial hemorrhage. It also describes the perioperative hematologic problems common to all types of surgery, but which may be accentuated in cerebrovascular surgical patients who are given anticoagulants prior to, during or after operation.


Factor VIII Disseminate Intravascular Coagulation Tranexamic Acid Fibrin Monomer Factor Viii Concentrate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.



  1. 1.
    Abbott WM, Maloney RD, McCabe CC, Lee CE, Wirthlin LS: Arterial embolism: a 44 year perspective. Am J Surg 143:460–464, 1982PubMedGoogle Scholar
  2. 2.
    Adams HP Jr: Current status of antifibrinolytic therapy for treatment of patients with aneurysmal subarachnoid hemorrhage. Stroke 13:256–259, 1982PubMedGoogle Scholar
  3. 3.
    Amundsen MA, Spittell JA Jr, Thompson JH Jr, Owen CA Jr: Hypercoagulability associated with malignant disease and the postoperative state; evidence for elevated levels of antihemophilic globulin. Ann Intern Med 58:608–616, 1963PubMedGoogle Scholar
  4. 4.
    Arneson H, Høiseth A, Ly B: Streptokinase or heparin in the treatment of deep vein thrombosis. Follow-up results of a prospective study. Acta Med Scand 211:65–68, 1982Google Scholar
  5. 5.
    Ashenhurst JB, Langehennig PL, Seeler RA: Early treatment of bleeding episodes with 10 U/ kg of factor VIII (Letter to editor). Blood 50:181–182, 1977PubMedGoogle Scholar
  6. 6.
    Bagge L, Björk I, Saldeen T, Wallin R: Purification of a fibrinolysis inhibitor in serum from post-traumatic patients. Thromb Haemost 39:97–108, 1978PubMedGoogle Scholar
  7. 7.
    Bashevkin ML, Nawabi IU: Factor XI deficiency in surgical patients. NY State J Med 79:1360–1362, 1979Google Scholar
  8. 8.
    Bergqvist D: Thrombotic and haemorrhagic problems in surgery (Letter to editor). Thromb Haemost 40: 572–573, 1979PubMedGoogle Scholar
  9. 9.
    Bergqvist D, Hallböök T: Thermography in screening postoperative deep vein thrombosis: A comparison with the 125I-fibrinogen test. Br J Surg 65:443–445, 1978PubMedGoogle Scholar
  10. 10.
    Bernacka I, Buczko W, Wisniewski K: Further studies on the effect of fibrinopeptides A and B on the central nervous system. Polish J Pharmacol Pharmacy 33:407–414, 1981Google Scholar
  11. 11.
    Bousser MG, Eschwege E, Haguenau M, Lefauconnier JM, Thibult N, Touboul D, Touboul PJ: Essai coopératif contrôlé “A.I.C.L.A.”. Prevention secondaire des accidents ischémiques cérébraux liés a l’athérosclésis par l’aspirine et le dipyridamole. 2e partie: description des sujets à l’entrée dans l’essai. Revue Neurol 138: 1–15, 1982Google Scholar
  12. 12.
    Bowie EJW, Owen CA Jr: The bleeding time. In Spaet TH (ed.): Progress in Hemostasis and Thrombosis, vol. 2. Grune & Stratton, New York, London, 1974, pp 249–271Google Scholar
  13. 13.
    Bowie EJW, Owen CA Jr: Diagnosis of bleeding and coagulation disorders. In Poller L (ed.): Recent Advances in Blood Coagulation. Churchill Livingstone, Edinburgh, London, New York, 1977, pp 59–89Google Scholar
  14. 14.
    Bowie EJW, Owen CA Jr: Hemostasic failure in clinical medicine. Semin Hematol 14:341–364, 1977PubMedGoogle Scholar
  15. Bowie EJW, Owen CA Jr: The bleeding diseases. Part I: History, physical examination and platelet diseases. MedCom Products. 1978, pp 1–48Google Scholar
  16. 16.
    Bowie EJW, Owen CA Jr: Platelet retention procedures. In Seligson D, Schmidt RM (eds.): CRC Handbook Series in Clinical Laboratory Science. Vol. I., Section I: Hematology. CRC Press, Boca Raton, 1979, pp 397–402Google Scholar
  17. 17.
    Bowie EJW, Owen CA Jr, Thompson JH Jr, Didisheim P: Platelet adhesiveness in von Willebrand’s disease. Am J Clin Pathol 52:69–77, 1969PubMedGoogle Scholar
  18. 18.
    Bramsen T: Fibrinolysis and traumatic hyphaema. Acta Ophthalmol 57:447–454, 1979Google Scholar
  19. 19.
    Bramsen T: Serum and aqueous humour concentration of tranexamic acid after peroral administration. Acta Ophthalmol 57:455–460, 1979Google Scholar
  20. 20.
    Brecher G: Enumeration of blood platelets: Methods and their validity. In Brinkhous KM, Shermer RW, Mostofi FK (eds.): The platelet. Williams & Wilkins Co, Baltimore, 1971, pp 358–364Google Scholar
  21. 21.
    Browse NL, Gray L, Morland M: Changes in the blood fibrinolytic activity after surgery (the effect of deep vein thrombosis and malignant disease). Br J Surg 64:23–27, 1977PubMedGoogle Scholar
  22. 22.
    Brueton MJ, Breeze GR, Stuart J: Fibrin-fibrinogen degradation products in cerebrospinal fluid. J Clin Pathol 29:341–344, 1976PubMedGoogle Scholar
  23. 23.
    Bump RL, Kolodny SC: Fibrinolysis: A possible factor in the control of postoperative hemorrhage in the patient with hemophilia. Oral Surg Oral Med Oral Pathol 36:195–200, 1973PubMedGoogle Scholar
  24. 24.
    Butler MJ, Bordon YB, Irving MH, Sola CM, Chard T: Serum levels of fibrin (ogen) degradation fragment E antigen in the diagnosis of deep vein thrombosis after abdominal and inguinal surgery. Thromb Res 8:167–171, 1976Google Scholar
  25. 25.
    Carlin G, Saldeen T: Influence of dextran 70 on the action of primary fibrinolysis inhibitor (“∝2-plasmin inhibitor”). Thromb Res 12:681–686, 1978PubMedGoogle Scholar
  26. 26.
    Cash JD, Das PC, Ruckley VA: Serum fibrin/ fibrinogen degradation products associated with post-operative pulmonary embolus and venous thrombosis. Scand J Haematol 13:323–326, 1971Google Scholar
  27. 27.
    Cerrato D, Ariano C, Fiacchino F: Deep vein thrombosis and low dose heparin prophylaxis in neurosurgical patients. J Neurosurg 49:378–381, 1978PubMedGoogle Scholar
  28. 28.
    Chaise LS, Comerota AJ, Soulen RL, Rubin RN: Selective intra-arterial streptokinase therapy in the immediate postoperative period. JAMA 247:2397–2400, 1982PubMedGoogle Scholar
  29. 29.
    Chen-sheng W, Chao-ski C, Tsu-tsai Y, Fu¬ching L: In vitro Radix salviae miltorrhizae action on blood anticoagulation and fibrinogenolysis. Haemostasis 8:58–63, 1979Google Scholar
  30. 30.
    Cliffton EE: Variations in the proteolytic and the antiproteolytic relations of serum: effect of disease, trauma, x-ray, anaphylactic shock, ACTH and cortisone. J Lab Clin Med 39:105–121, 1952PubMedGoogle Scholar
  31. 31.
    Coleman JB, Chang FC: Pulmonary embolism: an unrecognized event in severely burned patients. Am J Surg 130:697–699, 1975PubMedGoogle Scholar
  32. 32.
    Comp PC, Jacocks RM, Taylor FB Jr: The dilute whole blood clot lysis assay: a screening method for identifying postoperative patients with a high incidence of deep venous thrombosis. J Lab Clin Med 93:120–127, 1979PubMedGoogle Scholar
  33. 33.
    Cooke ED, Gordon YB, Bowcock SA, Sola CM, Pilcher MF, Chard T, Ibbotson RM, Ainsworth ME: Serum fibrin (ogen) degradation products in diagnosis of deep-vein thrombosis and pulmonary embolism after hip surgery. Lancet 2:51–54, 1975PubMedGoogle Scholar
  34. 34.
    Davies AJ, Strachan CJL, Hurlow RA, Stuart J: Fibrinolytic activity of tissue surfaces during surgery. J Clin Pathol 32:822–825, 1979PubMedGoogle Scholar
  35. 35.
    Davis JW, Davis RF, Hassanein KM: In healthy habitual smokers acetylsalicylic acid abolished the effects of tobacco smoke on the platelet aggregate ratio. Can Med Assoc J 126:637–639, 1982PubMedGoogle Scholar
  36. 36.
    Dechavanne J-M, Ville D, Clermont N, Pouillaude J-M, Clermont A, Viala J-J, de Mourges G: Le dosage radioimmunologique des products de degradation du fibrinogène possédant 1’antigène E, au cours des thromboses veineuses post-opératoires. Etude a l’occasion de 46 arthroplasties pour coxarthrose. Nouv Presse Med 6:3721–3724, 1977PubMedGoogle Scholar
  37. 37.
    Defaria CR, de Melo-Souza SE, Pinheiro ED: Haemophilic neuromyopathy. J Neurol Neuro-surg Psychiat 42:600–605, 1979Google Scholar
  38. 38.
    DeStefano F, Peterson HB, Ory HW, Layde PM: Oral contraceptives and postoperative venous thrombosis. Am J Obstet Gynecol 143:227–228, 1982PubMedGoogle Scholar
  39. 39.
    Dintenfass L: Blood Microrheology: Viscosity Factors in Blood Flow, Ischaemia and Thrombosis. Appleton-Century-Crofts, New York, 1971, p 445Google Scholar
  40. 40.
    Editorial: Surgery in haemophilia. Lancet 2: 206, 1977Google Scholar
  41. 41.
    Eika C, Havig Ø, Godal HC: The value of preoperative haemostatic screening. Scand J Haematol 21:349–354, 1978PubMedGoogle Scholar
  42. 42.
    Eyster ME, Gill FM, Blatt PM, Hilgartner MW, Ballard JO, Kinney TR, Hemophilia Study Group: Central nervous system bleeding in hemophiliacs. Blood 51:1179–1188, 1978PubMedGoogle Scholar
  43. 43.
    Filizzolo F, D’Angelo V, Collice M, Ferrara M, Donati ML, Porta M: Fibrinolytic activity in blood and cerebrospinal fluid in subarachnoid hemorrhage from ruptured intracranial saccular aneurysm before and during EACA treatment. Eur Neurol 17:43–47, 1978PubMedGoogle Scholar
  44. 44.
    Fletcher AP, Alkjaersig N, Lewis M, Tulevski V, Davies A, Brooks JE, Hardin WB, Landau WM, Raichle ME: A pilot study of urokinase therapy in cerebral infarction. Stroke 7:135–142, 1976aGoogle Scholar
  45. 44a.
    Fletcher AP, Alkjaersig N, Davies A, Lewis M, Brooks J, Hardin W, Landau W, Raichle ME: Blood coagulation and plasma fibrinolytic enzyme system pathophysiology in stroke. Stroke 7:337–348, 1976PubMedGoogle Scholar
  46. 45.
    Gafter U, Mandel EM, Weiss S, Djaldetti M: Primary fibrinolysis and spontaneous rupture of the spleen in acute lymphoblastic leukemia. Acta Haematol 56:355–359, 1976PubMedGoogle Scholar
  47. 46.
    Gamba G, Fornasari PM, Grignani G. Dolci D, Colloi D: Haemostasis during transvesical prostatic adenomectomy: A controlled trial on the effect of drugs with antifibrinolytic and thrombin-like activities. Blut 39:89–98, 1979PubMedGoogle Scholar
  48. 47.
    Gans H: Is primary fibrinolysis a real entity? (Editorial). Surg Gynecol Obstet 136:975–976, 1973PubMedGoogle Scholar
  49. 48.
    Gerrard JM, White JG: Prostaglandins and thromboxanes: “Middlemen” modulating platelet function in hemostasis and thrombosis. Prog Hemostasis Thromb 4:87–125, 1978Google Scholar
  50. 49.
    Gunn IG: Anti-Xa as a predictor of post operative deep vein thrombosis in general surgery. Br J Surg 66:636, 1979PubMedGoogle Scholar
  51. 50.
    Gurewich V, Hume M, Patrick M: The laboratory diagnosis of venous thromboembolic disease by measurement of fibrinogen/fibrin degradation products and fibrin monomer. Chest 64:585–590, 1973PubMedGoogle Scholar
  52. 51.
    Hamilton PJ, Dawson AA, Ogston D, Douglas AS: The effect of age on the fibrinolytic enzyme system. J Clin Pathol 27:326–329, 1974PubMedGoogle Scholar
  53. 52.
    Hanaway J, Torack R, Fletcher AP, Landau WM: Intracranial bleeding associated with urokinase therapy for acute ischemic hemispheral stroke. Stroke 7:143–146, 1976PubMedGoogle Scholar
  54. 53.
    Harms C: Laboratory evaluation of platelet function: platelet aggregation. In Triplett DA (ed.): Platelet Function: Laboratory Evaluation and Clinical Application. Amer Soc Clin Pathol, Chicago, 1978 pp 39–44Google Scholar
  55. 54.
    Hegt VN: Distribution and variation of fibrinolytic activity in the walls of human arteries and veins. Haemostasis 5:355–372, 1976PubMedGoogle Scholar
  56. 55.
    Hehne HJ, Nyman D, Burri H, Wolff G: Frischgefroren konserviertes Plasma zur Behandlung der intravasalen Gerinnung beim Polytraumatisierten. Schweiz Med Wochenschr 106:671–676, 1976PubMedGoogle Scholar
  57. 56.
    Hunter R, Thomson T, Reynolds CM, Pitcher PM: Fibrin/fibrinogen degradation products in cerebrospinal fluid of patients admitted to a psychiatric unit. J Neurol Neurosurg Psychiatry 37:249–251, 1974PubMedGoogle Scholar
  58. 57.
    Ibrahim AA, Dale WA: Disseminated intravascular coagulation after surgical excision of cavernous hemangioma. South Med J 72:760–761, 1979PubMedGoogle Scholar
  59. 58.
    Ito H, Yamamoto S, Komai T, Mizukoshi H: Role of local hyperfibrinolysis in the etiology of chronic subdural hematoma. J Neurosurg 45:26–31, 1976PubMedGoogle Scholar
  60. 59.
    Jaques LB: Heparin: An old drug with a new paradigm. Science 206:528–533, 1979Google Scholar
  61. 60.
    Kaste M, Ramsay M: Tranexamic acid in sub¬arachnoid hemorrhage. A double-blind study. Stroke 10:519–522, 1979PubMedGoogle Scholar
  62. 61.
    Kazmier FJ, Bowie EJW, Hagedorn AB, Owen CA Jr: Treatment of intravascular coagulation and fibrinolysis (ICF) syndromes. Mayo Clin Proc 49:665–672, 1974PubMedGoogle Scholar
  63. 62.
    Kimball ME, Milunsky A, Giannusa P, Carvalho ACA: Amniotic fluid fibrinogen degradation products in prenatal diagnosis of neural tube defects. Am J Obstet Gynecol 128:294–299, 1977PubMedGoogle Scholar
  64. 63.
    Knight MTN, Dawson R, Melrose DG: Fibrinolytic response to surgery; labile and stable patterns and their relevance to post-operative deep venous thrombosis. Lancet 2:370–373, 1977PubMedGoogle Scholar
  65. 64.
    Kobel M, Krahenbuhl B: Enquête sur la prévention de la thrombose veineuse profonde en chirurgie. Schweiz Med Wochenschr 112:148–152, 1982PubMedGoogle Scholar
  66. 65.
    Lane JL, Biggs R: The natural inhibitors of coagulation: Antithrombin III, heparin cofactor and antifactor Xa. In Poller L (ed.): Recent Advances in Blood Coagulation, number two. Churchill Livingstone, Edinburgh, London, New York, 1977, pp 123–139Google Scholar
  67. 66.
    Latallo ZS, Budzyński AZ, Lipiński B, Kowalski E: Inhibition of thrombin and of fibrin polymerization, two activities derived from plasmin-digested fibrinogen. Nature (Loud) 203:1184–1185, 1964Google Scholar
  68. 67.
    Leavelle DE, Bowie EJW, Mertens BF, McDuffie FC, Owen CA Jr: Assay for fibrinolytic split products; comparison of staphylococcal clumping and hemagglutination inhibition tests. J Lab Clin Med 77:993–999, 1971PubMedGoogle Scholar
  69. 68.
    Luterman A, Manwaring D, Curreri PW: Role of fibrinogen degradation products in pathogenesis of respiratory distress syndrome. Surgery 82:703–709, 1977PubMedGoogle Scholar
  70. 69.
    Lye RH, Paul KS, Forster CM, Whalley ET, Dutton J: Effect of fibrinogen degradation products on human basilar artery preparations: possible role in the etiology of cerebral arterial spasm. J Neurosurg 56:339–343, 1982PubMedGoogle Scholar
  71. 70.
    Marder VJ, Budzyfiski AZ: Data for defining fibrinogen and its plasmatic degradation products. Thromb Diath Haemorrhagica 33: 199–206, 1975Google Scholar
  72. 71.
    Marder VJ, Matchett MO, Sherry S: Detection of serum fibrinogen and fibrin degradation products: comparison of six technics using purified products and application in clinical studies. Am J Med 51:71–82, 1971PubMedGoogle Scholar
  73. 72.
    Maurice-Williams RS: Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intrancranial aneurysms? Br Med J 1:945–947, 1978PubMedGoogle Scholar
  74. 73.
    Mazza JJ, Bowie EJW, Hagedorn AB, Didisheim P, Taswell HF, Peterson LFA, Owen CA Jr: Antihemophilic factor VIII in hemophilia: Use of concentrates to permit major surgery. JAMA 211:1818–1823, 1970PubMedGoogle Scholar
  75. 74.
    Merskey C, Johnson AJ: The clinical significance of fibrinogen-fibrin-related antigen in serum. Scand J Haematol (suppl.) 13:313–315, 1971Google Scholar
  76. 75.
    Merskey C, Kleiner GJ, Johnson AJ: Quantitiative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. Blood 28:1–18, 1966PubMedGoogle Scholar
  77. 76.
    Mertens BF, McDuffie FC, Bowie EJW, Owen CA Jr: Rapid sensitive method for measuring fibrinogen split products in human serum. Mayo Clin Proc 44:114–120, 1969PubMedGoogle Scholar
  78. 77.
    Moriau M, Masure R, Hurlet A, Debeys C, Chalant C, Ponlot R, Jaumain P, Servaye-Ker-stens Y, Ravaux A, Louis A, Goenen M: Haemostasis disorders in open heart surgery with extracorporeal circulation. Importance of the platelet function and the heparin neutralization. Vox Sang 32:41–51, 1977PubMedGoogle Scholar
  79. 78.
    Nilsson IM: Determination of fibrinogen degradation products in serum and urine as a new diagnostic tool. Scand J Haematol 13:317–322, 1971Google Scholar
  80. 79.
    Owen CA Jr: Vitamin K-dependent proteins: historical development. Bibl Haematol 44:1–7, 1978Google Scholar
  81. 80.
    Owen CA Jr, Bowie EJW: Infusion therapy in hemophilia A and B. In Brinkhous KM, Hemker HC (eds.): Handbook of Hemophilia. Excerpta Medica, Amsterdam. 1975, pp 449–473Google Scholar
  82. 81.
    Owen CA Jr, Bowie EJW: Generation of coagulation factor V, XI and XII by the isolated rat liver. Haemostasis 6:205–212, 1977PubMedGoogle Scholar
  83. 82.
    Owen CA Jr, Bowie EJW, Fass DN: Generation of factor VIII coagulant activity by isolated, perfused neonatal pig livers and adult rat livers. Br J Haematol 43:307–315, 1979PubMedGoogle Scholar
  84. 83.
    Owen CA Jr, Bowie EJW, Thompson JH Jr: The Diagnosis of Bleeding Disorders, 2d ed. Little, Brown & Co, Boston, 1975, 398 ppGoogle Scholar
  85. 84.
    Penner JA, Kelly PE: Head injury in hemophiliacs (Letter to editor). JAMA 237:641, 1977PubMedGoogle Scholar
  86. 85.
    Ratnoff OD, Kaufman R: Arterial thrombosis in oral contraceptive users (Editorial). Arch Intern Med 142:447–448, 1982Google Scholar
  87. 86.
    Reganon E, Aznar J, Vila V: Degradation of human fibrinogen by plasmin; isolation and partial characterization of an early degradation product. Haemostasis 7:26–34, 1978PubMedGoogle Scholar
  88. 87.
    Rising DR, Brakman P, Redwood DR, Goldstein RE, Beiser GD, Astrup T, Epstein SE: Blood fibrinolytic activity in man; diurnal variation and the response to varying intensities of exercise. Circ Res 27:171–184, 1970Google Scholar
  89. 88.
    Ruckley CV, Das PC, Leitch AG, Donaldson AA, Copland WA, Redpath AT, Scott P, Cash JD: Serum fibrin/fibrinogen degradation products associated with postoperative pulmonary embolus and venous thrombosis. Br Med J 4:395–398, 1970PubMedGoogle Scholar
  90. 89.
    Salzman EW, Harris WH: Acetylsalicylic acid for prevention of venous thrombo-embolic disease in surgical patients. In Barnett HJM, Hirsh J, Mustard JF (eds.): Acetylsalicylic Acid: New Uses For an Old Drug. Raven Press, New York, 1982, pp 225–234Google Scholar
  91. 90.
    Sasahara AA, Sharma GVRK, Tow DE, McIntyre KM, Parisi AF, Cella G: Clinical use of thrombolytic agents in venous thromboembolism. Arch Intern Med 142:684–688, 1982PubMedGoogle Scholar
  92. 91.
    Sautter RD, Myers W0, Ray JF III, Wenzel FJ: Relationship of fibrinolytic system to postoperative thrombotic phenomena. Arch Surg 107:292–296, 1973PubMedGoogle Scholar
  93. 92.
    Sharma GVRK, Cella G, Parisi AF, Sasahara AA: Drug therapy: thrombolytic therapy. N Engl Med J 306:1268–1276, 1982Google Scholar
  94. 93.
    Smokovitis A: Regions of constantly increased plasminogen activator activity along the intima of the normal aorta. Haemostasis 7:303–319, 1978PubMedGoogle Scholar
  95. 94.
    Smokovitis A, Astrup T: Localization of fibrinolytic activity and inhibition of plasmin in the spinal cord of rat, guinea pig, and rabbit. J Neurosurg 48 1008–1014, 1978PubMedGoogle Scholar
  96. 95.
    Stamatakis JD, Lawrence D, Kakkar VV: Surgery, venous thrombosis and anti-Xa. Br J Surg 64:709–711, 1977PubMedGoogle Scholar
  97. 96.
    Stenflo J: Vitamin K and the biosynthesis of prothrombin. III. Structural comparison of an NH2-terminal fragment from normal and from dicoumarol-induced bovine prothrombin. J Biol Chem 248:6325–6332, 1973PubMedGoogle Scholar
  98. 97.
    Stormorken H: Interrelations between the coagulation-, the fibrinolytic and the kallikreinkinin system. Scand J Haematol (suppl.) 34:24–27, 1979Google Scholar
  99. 98.
    Sutor AH, Bowie,EJW, Owen CA Jr: Effect of aspirin, sodium salicylate, and acetaminophen on bleeding. Mayo Clin Proc 46:178–181, 1971PubMedGoogle Scholar
  100. 99.
    Sutor AH, Bowie EJW, Thompson JH Jr, Didisheim P, Mertens BF, Owen CA Jr: Bleeding from standardized skin punctures: automated technic for recording time, intensity and pattern of bleeding. Am J Clin Pathol 55:541–550, 1971PubMedGoogle Scholar
  101. 100.
    Takagi K, Kawai T: Radioimmunoassay of an elderly plasmin degradation product of human fibrinogen, “fragment A,” and its clinical application. Thromb Haemost 39:1–11, 1978PubMedGoogle Scholar
  102. 101.
    Tovi D: Fibrinolytic activity of human brain. A histochemical study. Acta Neurol Scand 49:152–162, 1973PubMedGoogle Scholar
  103. 102.
    Tovi D, Thulin CA: Ability of tranexamic acid to cross the blood-brain barrier and its use in patients with ruptured intracranial aneurysms (Abstract). Acta Neurol Scand 48:257, 1972Google Scholar
  104. 102a.
    Vogel GE, Fritsche HM, Stemberger A, Reiter C, Blumel G. Untersuchungen zur Hamostase bei Hämodialyse polytraumatisierter Patienten unter Minimal-Heparinisierung. Langenbecks Arch Chir 347:655, 1978Google Scholar
  105. 103.
    Weiss RR, Macri JN, Merskey C: F.D.P. in amniotic fluid as marker for neural-tube defects (Letter to editor). Lancet 1:304, 1976PubMedGoogle Scholar
  106. 104.
    Zahavi J, Price AJ, Kakkar VV: Enhanced platelet release associated with general anaesthesia. Lancet 1:1132–1133, 1980PubMedGoogle Scholar


  1. Adams E: Postoperative thrombocytosis. Arch Intern Med 73:329–335, 1944Google Scholar
  2. Allen EV: Changes in the blood following operation. Arch Surg 15:254–264, 1927Google Scholar
  3. Arkel YS, Haft JI, Kreutner W, Sherwood J, Williams R: Alteration in second phase platelet aggregation associated with an emotionally stressful activity. Thromb Haemost 38:552–561, 1977PubMedGoogle Scholar
  4. Auer L: Disturbances of coagulatory system in patients with severe cerebral trauma. Acta Neurochir 43:51–59, 1978Google Scholar
  5. Baehner RL: Alterations in blood coagulation with trauma. Pediatr Clin North Amer 22:289–299, 1975Google Scholar
  6. Bagge L, Saldeen T: The primary fibrinolysis inhibitor and trauma. Thromb Res 13:1131–1136, 1978PubMedGoogle Scholar
  7. Bansal BC, Prakash C, Arya RK, Gulati SK, Mittal, SC: Serum lipids, platelets, and fibrinolytic activity in cerebrovascular disease. Stroke 9:137–139, 1978PubMedGoogle Scholar
  8. Berkarda B, Akokan G, Derman U: Fibrinolytic response to physical exercise in males. Atherosclerosis 13:85–91, 1971PubMedGoogle Scholar
  9. Bernard J, Soulier JP: Sur une nouvelle variété de dystrophie thrombocytaire-hémorragipare congénitale. Sem Hop Paris 24:3217–3223, 1948PubMedGoogle Scholar
  10. Berry CG: A preliminary communication on the de-generation of thrombin in serum of normal controls and of patients before or after surgery. J Clin Pathol 9:363–367, 1956PubMedGoogle Scholar
  11. Beurling-Harbury C, Galvan CA: Acquired decrease in platelet secretory ADP associated with increased postoperative bleeding in post-cardiopulmonary bypass patients with severe valvular heart disease. Blood 52:12–23, 1978Google Scholar
  12. Boshamer K: Untersuchungen zur Enstehung post-operativer Thrombosen Klin Wochenschr 6:740–742, 1927Google Scholar
  13. Boucays A, Charlet JP, Boneu P, Puel R: Hyper consommation plaquettaire apres chirurgie arterielle. Effects de 1’association dipyridamole-aspirine. Nouv Presse Méd 4:1734–1735, 1975Google Scholar
  14. Britton BJ, Wood WG, Smith M, Hawkey C, Irving MH: The effect of beta adrenergic blockade upon exercise-induced changes in blood coagulation and fibrinolysis. Thromb Haemost 35:396–402, 1976PubMedGoogle Scholar
  15. Brown JE, Baugh RF, Hougie C: Effect of exercise on the factor VIII complex; a correlation of the von Willebrand antigen and factor VIII coagulant antigen increase. Thromb Res 15:61–67, 1979PubMedGoogle Scholar
  16. Brown LK, Haggart B, Murray GH, Downie RJ, Littler J, Robb PM, Santer GJ: Pharmacological stimulation of fibrinolytic activity in the surgical patient. Lancet 1:774–776, 1971PubMedGoogle Scholar
  17. Burkhardt K, Peitsch W: Veränderungen des Gerinnungsund Fibrinolysesystems im traumatischen Schock unter besonderer Berucksichtigung des Lymphsystems. Langenbecks Arch Chir 338:81–90, 1975PubMedGoogle Scholar
  18. Call FL II, Schroeder ET, Parker FB Jr, Davey FR: Fibrin-fibrinogen degradation products in cardiovascular surgery. Arch Surg 107:834–837, 1973PubMedGoogle Scholar
  19. Ciavatti M, Michel G, Dechavanne M: Platelet phospholipids in venous thrombosis after surgical operation. Biochem Med 17:180–186, 1977PubMedGoogle Scholar
  20. Davies T, Lederer DA, Davies JA, McNichol GP: The effect of aspirin on the exercise-induced changes in platelet function and blood coagulation. Thromb Res 5:69–81, 1974PubMedGoogle Scholar
  21. Demirjian Z, Sara M, Stulberg D, Harris WH: Disseminated intravascular coagulation in patients undergoing orthopedic surgery. Clin Orthop 102:174–180, 1974PubMedGoogle Scholar
  22. Didisheim P, Fuster V: Actions and clinical status of platelet-suppressive agents. Semin Hematol 15:55–72, 1978PubMedGoogle Scholar
  23. Dimitriadou C, Dessypris A, Louizou C, Mandalaki T: Marathon run. II. Effects on platelet aggregation. Thromb Haemost 37:451–455, 1977PubMedGoogle Scholar
  24. Doutremepuich C: Haemostasis defects following cardio-pulmonary by-pass based on a study of 1350 patients. Thromb Haemost 39:539–541, 1978 Doutremepuich C, Oca C, Coqueran JE, Chauve A, Ruffié P, Baudet E, Fontan F: Variations de la coagulation dans la chirurgie cardiaque en hy-pothermie profonde. Nouv Rev Franc Hematol 16:285, 1976Google Scholar
  25. Drayer BP, Poser CM: Disseminated intravascular coagulation and head trauma. JAMA 231:174–175, 1975PubMedGoogle Scholar
  26. Dyken ML: Assessment of the role of antiplatelet aggregating agents in transient ischemic attacks, stroke and death. Stroke 10:602–604, 1979Google Scholar
  27. Economopoulos TC, Papayannis AG, Stathakis NE, Arapakis G, Gardikas C: Postoperative platelet function in patients on small subcutaneous doses of heparin. Acta Haematol 57:266–271, 1977PubMedGoogle Scholar
  28. Egan EL, Bowie EJW, Kazmier FJ, Gilchrist GS, Woods JW, Owen CA Jr: Effect of surgical operations on certain tests used to diagnose intravascular coagulation and fibrinolysis. Mayo Clin Proc 49: 658–664, 1974PubMedGoogle Scholar
  29. Egeberg O: Changes in the coagulation system following major surgical operations. Acta Med Scand 171:679–685, 1962PubMedGoogle Scholar
  30. Feruglio G, Sandberg H, Bellet S: Postoperative changes in blood coagulation in elderly patients. Am J Cardiol 5:447–482, 1960Google Scholar
  31. Fletcher AP, Alkjaersig N, Davies A, Lewis M, Brooks J, Hardin W, Landau W, Raichle ME: Blood coagulation and plasma fibrinolytic enzyme system pathophysiology in stroke. Stroke 7:337–348, 1976bGoogle Scholar
  32. Fletcher AP, Alkjaersig NK, O’Brien J, Tulevski V: Fibrinogen catabolism in the surgically treated pa-tient and in those with postoperative venous thrombosis. Correlation of plasma fibrinogen chro-matographic findings with 125I-labeled fibrinogen scan findings. J Lab Clin Med 89:1349–1364, 1977PubMedGoogle Scholar
  33. Fratantoni JC: Thrombolytic therapy (editorial). Am Heart J 93:271–273, 1977PubMedGoogle Scholar
  34. Fredén K, Lundborg P, Vilén L, Kutti J: The peripheral platelet count in response to adrenergic alpha-and beta- l -receptor stimulation. Scand J Haematol 21:427–432, 1978PubMedGoogle Scholar
  35. Gardikas C, Tsakayannis E, Thomapoulos D: Post-operative changes in the results of coagulation tests. Acta Haematol 21:129–138, 1959PubMedGoogle Scholar
  36. Glanzmann E: Hereditäre hämorrhagische Thrombasthenie: Ein Beitrag zur Pathologie der Blutplättchen. Jahrb Kinderheilkd 88:1–42, 113–141, 1918Google Scholar
  37. Godal HC: Quantitative and qualitative changes in fibrinogen following major surgical operation. Acta Med Scand 171:687–694, 1962PubMedGoogle Scholar
  38. Godal HC, Fichera C: Heparin thrombin time and plasma proteins after major operations. Acta Med Scand 170:417–421, 1961PubMedGoogle Scholar
  39. Griffiths NJ, Woodford M, Irving MH: Plasma fibrinolytic inhibitors after operation. Surg Gynecol Obstet 144:673–676, 1977PubMedGoogle Scholar
  40. Gurewich V, Lipinska I, Lipinski B: Exercise-induced fibrinolytic activity and its effect on the degradation of fibrinogen, fibrin and fibrin-like precipitates. Thromb Res 5:647–656, 1974PubMedGoogle Scholar
  41. Harker LA, Slichter SJ: Platelet and fibrinogen consumption in man. Engl J Med 287:999–1005, 1972Google Scholar
  42. Hirsh J: Diagnosis of venous thrombosis. Thromb Haemost 41:450–453, 1979PubMedGoogle Scholar
  43. Holmsen H, Weiss HJ: Hereditary defect in the platelet release reaction caused by a deficiency in the storage pool of platelet adenine nucleotides. Br J Haematol 19:643–649, 1970PubMedGoogle Scholar
  44. Horowitz RE, Tatter D: Lethal pulmonary embolism. In Sherry S, Brinkhous KM, Genton E, Stengle JM (eds.): Thrombosis. National Academy of Sciences, Washington, DC, 1969, pp 19–28Google Scholar
  45. Hougie C, McPherson RA, Aronson L: Passovoy factor: A hitherto unrecognized factor necessary for haemostasis. Lancet 2:290–291, 1975PubMedGoogle Scholar
  46. Karp JE, Bell WR: Fibrinogen-fibrin degradation products and fibrinolysis following exercise in hu-man. Am J Physiol 227:1212–1215, 1974PubMedGoogle Scholar
  47. Keber K, Stegnar M, Keber I, Accetto B: Influence of moderate and strenuous daily physical activity on fibrinolytic activity of blood: possibility of plasminogen activator stores depletion. Thromb Haemost 41:745–755, 1979PubMedGoogle Scholar
  48. Korsan-Bengtsen K, Conradrson TB: Influence of two different beta-adrenergic blocking agents on the increase in fibrinolytic activity and factor VIII activity during submaximum and maximum exercise. Scand J Haematol 13:377–384, 1974PubMedGoogle Scholar
  49. Levites R, Haft JI: Effects of exercise-induced stress on platelet aggregation. Cardiology 60:304–314, 1975PubMedGoogle Scholar
  50. Levy G, Jamet M, Roux F, Paulin R, Frangois G: Évolution du taux de fragment E du fibrinogène au cours de la période post-opératoire. Nouv Presse Med 7:3253, 1978Google Scholar
  51. Lewis RT: Severe coagulopathy following insertion of LeVeen shunt: A potentially fatal complication. Can J Surg 22:361–363, 1979PubMedGoogle Scholar
  52. Lichtenfeld KM, Schiffer CA, Helrich M: Platelet aggregation during and after general anesthesia and surgery. Anesth Analg 58:293–296, 1979PubMedGoogle Scholar
  53. Loew D, Wiedemann R, Remmele W: Gerinnungsanalytische and pathologisch-anatomische Untersuchungen beim traumatischen Schock. Klin Wochenschr 49:1101–1108, 1971PubMedGoogle Scholar
  54. Maki M, Nagayama M, Oda T, Shinagawa S: Anticoagulant release during shock. Thromb Res 8 (suppl. 2):159–163, 1976PubMedGoogle Scholar
  55. Mandalaki T, Dessypris A, Louizou C, Bossinakou I, Panayotopoulou C, Antonopoulou A: Marathon run. I. Effects on blood coagulation and fibrinolysis. Thromb Haemost 37:444–450, 1977PubMedGoogle Scholar
  56. Maslowski WC: The effect of surgery in blood coagulation. J Oral Surg 18:97–107, 1960Google Scholar
  57. Matseshe JW, Beart RW Jr, Bartholomew LG, Baldus WP: Fatal disseminated intravascular coagulation after peritoneovenous shunt for intractable ascites. Mayo Clin Proc 53:526–528, 1978PubMedGoogle Scholar
  58. Mauersberger W: Sekundäre Störungen der Blutgerinnung bei schweren Schädelhirntraumen. Neurochirurgia 22:68–72, 1979PubMedGoogle Scholar
  59. Menon IS, Burke F, Dewar HA: Effect of strenuous and graded exercise on fibrinolytic activity. Lancet 1:700–702, 1967PubMedGoogle Scholar
  60. Mulcare RJ, Royster TS, Phillips LL: Intravascular coagulation in surgical procedures on the abdomina aorta. Surg Gynecol Obstet 143:730–734, 1976PubMedGoogle Scholar
  61. Müller N, Popov-Cenić S, Büttner W, Kladetzky RG, Egli H: Studies of fibrinolytic and coagulation factors druing open heart surgery. II. Postoperative bleeding tendency and changes in the coagulation system. Thromb Res 7:589–598, 1975PubMedGoogle Scholar
  62. Nath P, Srivastava OP, Chandra D, Gahlaut VVS, Singh MP: Studies on fibrinolytic activity. I. Fibrinolytic activity after surgical operations. Indian J Surg 31:26–31, 1969Google Scholar
  63. Owen CA Jr, and Bowie EJW: The diagnosis of platelet abnormalities. Excerpta Med Int Congr ser. 357:226–233, 1975Google Scholar
  64. Owen CA Jr, Bowie EJW: The intravascular coagulation-fibrinolysis syndromes in obstetrics and gynecology. Upjohn Company., 1976, 36 ppGoogle Scholar
  65. Owen CA Jr, Bowie EJW: Surgical hemnostasis. J Neurosurg 51:137–146, 1979PubMedGoogle Scholar
  66. Owen CA Jr Bowie EJW, Fass DN, Perez RA, Cole TL, Stewart M: Hypofibrinogenemia-dysfibrinogenemia and von Willebrand’s disease in the same family. Mayo Clin Proc 54:375–380, 1979PubMedGoogle Scholar
  67. Panakhian AG: Fluctuations in the level of prothrombin, thrombin, free heparin and the activity of thromboplastin in the blood of patients after surgery on the organs of the intestinal cavity (Russ.). Khirurgiia 36:113–119, 1960PubMedGoogle Scholar
  68. Pepper H, Lindsay S: Responses of platelets, eosinophils, and total leukocytes during and following surgical procedures. Surg Gynecol Obstet 110:319–326, 1960PubMedGoogle Scholar
  69. Popov-Cenić S, Müller N, Kladetzky R-G, Hack G, Lang U, Safer A, Rahlfs VW: Durch Prämedikation, Narkose and Operation bedingte Änderungen des Gerinnungs- and Fibrionlysesystems and der Thrombozyten; Einfluss von Dextran and Hydroxyäthylstarke (HÄS) während and each Operation. Der Anaesthetist 26:77–84, 1977Google Scholar
  70. Potts WJ, Pearl E: A study of the platelet count and the coagulation time of plasma and whole blood following operation. Surg Gynecol Obstet 73:492–494, 1941Google Scholar
  71. Pruna A, Gineston J-L, Capron JP, Capron-Chivrac D, Dupas J-L, Lorriaux A: Coagulation intravasculaire disséminée après mise en place d’une valve de Le Veen. Gastroenterol. Clin. Biol. 3:406–407, 1979Google Scholar
  72. Risberg B: Fibrinolysis and trauma. Eur Surg Res 10:373–381, 1978PubMedGoogle Scholar
  73. Rodvien R, Mielke CH Jr: Platelet and antiplatelet agents in strokes. Curr. Concepts Cerebrovasc. Dis Stroke 13:5–8, 1978Google Scholar
  74. Rodvien R, Mielke CH Jr: Platelet and antiplatelet agents in stroke. Stroke 9:403–405, 1978PubMedGoogle Scholar
  75. Rodvien R, Salzman EW: Thrombotic and hemorrhagic problems in surgery. Thromb Haemost 39:254–262, 1978PubMedGoogle Scholar
  76. Sandrock RS, Mahoney EB: Prothrombin activity: a diagnostic test for early postoperative venous thrombosis. Ann Surg 128:521–532, 1948Google Scholar
  77. Sautter RD, Larson DE, Bhattacharyya SK, Chen H-M, Treuhaft PS, Milbauer JP, Mazza JJ, Emanuel DA, Kock EL, Lolley DM, Myers WO, Ray JF III, Plotka ED, Nycz GR, Wenzel FJ: Limited utility of fibrinogen-I-125 leg scanning. Arch Intern Med 139:148–153, 1979PubMedGoogle Scholar
  78. Sefrin P, Brunswig D, Hauptvogel S: Der Einfluss von Bluttransfusonen auf die Veranderungen der Hämostase bei polytraumatisierten Verletzten. Der Anaesthetist 26:288–294, 1977Google Scholar
  79. Slichter SJ, Funk DD, Leandoer LE, Harker LA: Kinetic evaluation of haemostasis during surgery and wound healing. Br J Haematol 27:115–125, 1974PubMedGoogle Scholar
  80. Stibbe J: Effect of exercise on F VIII-complex: Proportional increase of ristocetin cofactor (von Willebrand factor) and F VIII-AGN, but disproportional increase of F VIII-AHF. Thromb Res 10:163–168, 1977PubMedGoogle Scholar
  81. Taberner DA, Poller L, Burslem RW: Antiplasmin concentrations after surgery: failure of alpha2-antiplasmin to rise in patients with venous thrombosis. Br Med J 1:1122–1123, 1979PubMedGoogle Scholar
  82. Törngren S, Norén I, Savidge G: The effect of low-dose heparin of fibrinopeptide A, platelets, fibrinogen degradation products and other haemostatic parameters measured in connection with intestinal surgery. Thromb Res 14:871–879, 1979PubMedGoogle Scholar
  83. Uihlein A, Bowie EJW, Thompson JH Jr: Profound hypothermia techniques in neurologic surgery: hemorrhagic complications. In Ulin AW, Gollub SS (eds.): Surgical Bleeding; Handbook for Medicine, Surgery, and Specialties. Blakiston Div., McGraw-Hill Book Co. New York, 1966, pp 445–449Google Scholar
  84. Umlas J: Fibrinolysis and disseminated intravascular coagulation in open heart surgery. Transfusion 16:460–463, 1976PubMedGoogle Scholar
  85. van der Sande JJ, Veltkamp JJ, Boekhout-Mussert RJ, Bouwhuis-Hoogerwerf ML: Head injury and coagulation disorders. J Neurosurg 49:357–365, 1978PubMedGoogle Scholar
  86. Vecht CJ, Smit Sibinga CT, Minderhoud JM: Disseminated intravascular coagulation and head injury. J Neurol Neurosurg Psychiatry 38:567–571, 1975PubMedGoogle Scholar
  87. Vogel GE, Fritsche H-M, Stemberger A, Reiter C, Blumel G: Untersuchungen zur Hämostase bei Hämodialyse polytraumatisierter Patienten unter Minimal-Heparinisierung. Langenbecks Arch Chir 347:655, 1978Google Scholar
  88. Vogt A, Hofmann V, Straub PW: Lack of fibrin formation in exercise-induced activation of coagulation. Am J Physiol 236:H577–H579, 1979PubMedGoogle Scholar
  89. Warlow CP, Ogston D: Effect of exercise on platelet count, adhesion, and aggregation. Acta Haematol 52:47–52, 1974PubMedGoogle Scholar
  90. Warren R: Postoperative thrombophilia. N Engl J Med 249:99–106, 1953PubMedGoogle Scholar
  91. Weiss HJ, Rogers J: Thrombocythopathia due to abnormalities in platelet release reaction: Studies on six unrelated patients. Blood 39:187–196, 1972PubMedGoogle Scholar
  92. Wille P: Das Verhalten des Plasma-Thrombokinase-Bildungstestes wahrend Operation and Narkose. Arch Gynäkol 192: 78–84, 1959PubMedGoogle Scholar
  93. Williams JA, Warren R: Endocrine factors in the alterations of the blood coagulation mechanism after surgery. J Lab Clin Med 50:372–375, 1957PubMedGoogle Scholar
  94. Wilson RF, McCarthy B, LeBlanc LP, Mammen E: Respiratory and coagulation changes after uncomplicated fractures. Arch Surg 106:395–399, 1973PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1985

Authors and Affiliations

  • Charles A. OwenJr.
  • E. J. Walter Bowie

There are no affiliations available

Personalised recommendations